METHYL 2,5-DIMETHYL-3-(PYRIDIN-4-YL)ISOXAZOLIDINE-5-CARBOXYLATE, 90.0%, 1g

5-bromo-3-cyclopentyl-1H-1,2,4-triazole, 95.0%, 250mg

6,6',6''-(2,4,6-Trimethylbenzene-1,3,5-triyl)tris(2-naphthoic acid), 97%, 1g

2-(3,5-Difluoro-4-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

2-NITRO-6-(TRIFLUOROMETHOXY)ANISOLE, 95.0%, 250mg

1-Aminocyclopropanecarboxamide, 95.0%, 1g

5-Bromo-2-ethoxy-4-methylpyridine, 95.0%, 5g

4-[2-(2-Hydroxyethoxy)ethyl]morpholine, 97.0%, 1g

Anti-NeuGc Polyclonal Antibody R-PE Conjugate1vial

4-Bromo-3-hydroxy-2-naphthoic Acid>97.0%(GC)(T)5g

Pipeta microlitro monocanal Eppendorf Research® plus, 500 a 5000 µl, lila, 1 unidad

2-Bromo-9-(2-naphthyl)-9H-carbazole, 98% GC, 1g

1-(3,4-Dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propan-1-one, 97%, 10g